Publication | Closed Access
HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
129
Citations
44
References
2012
Year
Hematological MalignancyTumor BiologyChromatinDeacetylase Inhibitor TreatmentMedicineEpigenomicsPathologyMedulloblastoma ModelNovel Group 3Cancer GeneticsSystems BiologyOncologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1